PD-1 Inhibitor for Disseminated Mycobacterium avium Infection in a Person With HIV
Authors:
Open Access
- 28 December 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 10 (1) , ofac700
Abstract
We reported a case of people living with HIV with disseminated Mycobacterium avium (M.avium) infection, in whom antiretroviral therapy combined with all drugs that of anti-M.avium activities failed to clear the pathogen. After PD-1 inhibitor treatment, T cells exhaustion was reversed and M.avium-specific T cell response was boosted, together with M.avium clearance.Keywords
Funding Information
- Science and Technology Commission of Shanghai Municipality (21Y11901200)
- Shanghai Human Resources and Social Security Bureau (2020089)
- Shanghai Municipal Hospital Development Center (SHDC2020CR4005, SHDC2020CR6025)
This publication has 13 references indexed in Scilit:
- T‐cell exhaustion in HIV infectionImmunological Reviews, 2019
- The association of PD-L1 expression with the efficacy of anti-PD-1/PD-L1 immunotherapy and survival of non-small cell lung cancer patients: a meta-analysis of randomized controlled trialsTranslational Lung Cancer Research, 2019
- Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trialThe Lancet, 2019
- Pembrolizumab Treatment for Progressive Multifocal LeukoencephalopathyNew England Journal of Medicine, 2019
- Role of Mycobacterium avium lysate INF-γ, IL-17, and IL-2 ELISPOT assays in diagnosing nontuberculous mycobacteria lymphadenitis in childrenEuropean Journal of Clinical Microbiology & Infectious Diseases, 2019
- Improvement of Mycobacterium abscessus Pulmonary Disease after Nivolumab Administration in a Patient with Advanced Non-small Cell Lung CancerInternal Medicine, 2018
- Immune checkpoint blockade in infectious diseasesNature Reviews Immunology, 2017
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung CancerNew England Journal of Medicine, 2016
- Epidemiology of Human Pulmonary Infection with Nontuberculous MycobacteriaClinics in Chest Medicine, 2015
- Inhibitory Receptors on Lymphocytes: Insights from InfectionsThe Journal of Immunology, 2012